Paper6974593
Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants.
Dennis JW and 3 others. Cancer Res, 1981. Cited by 31 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants. Papers, record 6974593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6974593
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| H-2 Antigens | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Cell Line | |
| Cell Membrane | |
| Cytotoxicity, Immunologic | |
| Endoplasmic Reticulum | |
| Lectins | |
| Mice | |
| Mice, Inbred DBA | |
| Mice, Nude | |
| Microsomes | |
| T-Lymphocytes | |
| Trinitrobenzenes |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6764377 | Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/6764377 | PubMed |
| 6764376 | Experimental systems for analysis of the malignant phenotype. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/6764376 | PubMed |
| 6607103 | Differences in the metastatic potential of two sublines of tumor 3LL selected for resistance to natural NK-like effector cells. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6607103 | PubMed |
| 6237114 | Identification of asparagine-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen. | J Cell Biol | 1984 | https://conductscience.org/library/papers/6237114 | PubMed |
| 3902300 | Implications of tumor progression on clinical oncology. | Clin Exp Metastasis | 1985 | https://conductscience.org/library/papers/3902300 | PubMed |
| 3549035 | Tumor cell surface carbohydrate and the metastatic phenotype. | Cancer Metastasis Rev | 1987 | https://conductscience.org/library/papers/3549035 | PubMed |
| 3081900 | Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3081900 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6974593
GET https://conductscience.org/api/papers/v1/6974593/authors